INTERPACE BIOSCIENCES, INC. cotiza a 6.13 USD y tiene una capitalización bursátil de $36M. En los últimos 12 meses ha facturado $36M con un margen de flujo de caja libre del 14.1%. Cotiza a 8.8 veces su flujo de caja libre (P/FCF) y a un PER de 1.5. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Interpace Biosciences, Inc. provides molecular diagnostic tests and pathology services for evaluating cancer risk in the United States. It offers ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. The company also provides ThyraMIR v2, which assesses thyroid nodules for malignancy risk using …
| Métrica | IDXG | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 62.3% | 57.0% | +5.3% |
| Operating Margin | 10.6% | -38.6% | +49.2% |
| Net Margin | 63.5% | -33.6% | +97.0% |
| FCF Margin | 14.1% | -13.9% | +28.0% |
| ROE | 109.9% | -40.4% | +150.3% |
| ROA | 72.6% | -32.0% | +104.6% |
| Current Ratio | 1.94 | 2.84 | -0.90 |
| Debt / Equity | — | 0.28 | — |